Trial: 202112086

A dose escalation and dose expansion study of NOX66 plus doxorubicin in anthracycline-naïve, adult patients with soft tissue sarcoma – CEP-2

Phase

I (Cancer Control)

Principal Investigator

Weiss, Mia

Disease Site

Soft Tissue

Learn more about this study at: clinicaltrials.gov